Lung Cancer Clinical Trial

Tempus NSCLC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With NSCLC Using NGS Assays

Summary

Non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal plasma biomarker profiling in addition to their standard of care therapy and disease surveillance.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

A known or suspected lung cancer
Undergoing or has undergone a transbronchial needle aspiration (TBNA) or lung biopsy of a lung nodule or lung mass or thoracic lymph node biopsy for the purpose of diagnosis or staging of lung cancer
Patients who don't undergo a biopsy and instead move directly to a surgical resection as dictated by the treating physician will be allowed to enter the study at the relevant time point
18 years old or older
Willing and able to provide informed consent
Willing to have additional blood samples collected during routine surveillance visits
Lung cancer diagnosis post-initial biopsy or resection

Exclusion Criteria:

Suspected sarcoidosis, lymphoma, or metastatic cancer from other sites (i.e., those without a known or suspected lung primary diagnosis)
Not willing to have additional blood samples collected

Study is for people with:

Lung Cancer

Estimated Enrollment:

338

Study ID:

NCT05236114

Recruitment Status:

Recruiting

Sponsor:

Tempus Labs

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

MemorialCare
Fountain Valley California, 92708, United States More Info
Tuyet Collucci
Contact
562-706-1195
[email protected]
Amol Rao, MD
Principal Investigator
Aultman Hospital
Canton Ohio, 44710, United States More Info
Carla Larch
Contact
330-363-1250
[email protected]
Sareena Singh, MD
Principal Investigator
TriHealth Cancer Institute
Cincinnati Ohio, 45220, United States More Info
Wayne Thompson
Contact
513-865-5020
[email protected]
Leanne Budde, MD
Principal Investigator
ThedaCare Regional Cancer Center
Appleton Wisconsin, 54911, United States More Info
Rachel Luedtke
Contact
920-364-3616
[email protected]
Matthias Weiss, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

338

Study ID:

NCT05236114

Recruitment Status:

Recruiting

Sponsor:


Tempus Labs

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider